Saturday, August 03, 2024 1:40:01 PM
HyGro, your facts are biased, and your numbers are way off base,
"There have been 8 publications that have documented to trial defects."
Should state, there have been 8 publications that have been paid to print and fabricate the truth by lying about trial defects.
However, there are over 300+ oncologists, cancer doctors, cancer research centers, and universities that support NWBO's effort to move forward for approvals. So, there is a 300+ to 8 ratio that support NWBO.
It is only your opinion that "NWBO has violated FDA guidelines for oncology comparators"
In fact, there is zero basis that NWBO has violated FDA guidelines for oncology comparators, IMPO.
Plain and simple, your attempts to fool this board fail time and time again, IMPO.
"There have been 8 publications that have documented to trial defects."
Should state, there have been 8 publications that have been paid to print and fabricate the truth by lying about trial defects.
However, there are over 300+ oncologists, cancer doctors, cancer research centers, and universities that support NWBO's effort to move forward for approvals. So, there is a 300+ to 8 ratio that support NWBO.
It is only your opinion that "NWBO has violated FDA guidelines for oncology comparators"
In fact, there is zero basis that NWBO has violated FDA guidelines for oncology comparators, IMPO.
Plain and simple, your attempts to fool this board fail time and time again, IMPO.
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
